ArticleThe international journal of cardiovascular imaging2025
The value of left ventricular T1 mapping and left atrial strain for distinguishing myocardial amyloidosis and hypertrophic cardiomyopathy.
Article in The international journal of cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to use T1 mapping and left atrial feature tracking techniques to distinguish myocardial amyloidosis (CA) from hypertrophic cardiomyopathy (HCM).
methodsA retrospective analysis was conducted on 130 subjects who underwent cardiac magnetic resonance examinations from January 2021 to May 2024 at 1.5 and 3.0 T systems. Measurements of global left ventricular myocardial T1 values were performed, a standardized T1 z-score used as an assessment metric to overcome the effects of various manufacturers and field strengths. Left atrial strain was measured with feature tracking techniques.
results42 CA patients、58 HCM patients and 30 healthy subjects were analyzed. For both 1.5T and 3.0T systems, the overall T1 values of LV myocardium was significantly higher in the CA group compared with the HCM and control groups (p < 0.001). T1z-scores in the CA and HCM groups were 4.8 ± 2.2 and 3.4 ± 1.9, respectively (p < 0.001). Myocardial strain analysis showed that atrial strain was significantly lower in the CA group when compared with the HCM and healthy control groups (p < 0.05). The correlation between left atrial strain and function parameters was assessed through Spearman correlation analysis. Multivariate logistic regression analysis showed that a combination model including T1z-score and left atrial reservoir function (Es) had an improved ability to discriminate CA and HCM with a higher AUC (0.937), with a sensitivity of 95.2% and a specificity of 83.3% (P < 0.05).
conclusionT1 mapping combined with Εs could effectively distinguish CA from HCM, and provide new insights for the diagnosis of the etiology and treatment of cardiac hypertrophic diseases.
Indexed as
Identifiers
40301201What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.